Effects of platycodins on liver complications of type 2 diabetes

Luan,Haiyan; Yang,Limin; Liu,Lei; Liu,Shuang; Zhao,Xiaolian; Sui,Hongyu; Wang,Jingtao; Wang,Shuqiu

doi:10.3892/mmr.2014.2363

Effects of platycodins on liver complications of type 2 diabetes

Authors:
- Haiyan Luan
- Limin Yang
- Lei Liu
- Shuang Liu
- Xiaolian Zhao
- Hongyu Sui
- Jingtao Wang
- Shuqiu Wang
View Affiliations

Affiliations: Department of Basic Medical Sciences, Jiamusi University, Jiamusi, Heilongjiang 154007, P.R. China
Published online on: July 4, 2014 https://doi.org/10.3892/mmr.2014.2363
Pages: 1597-1603

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the current study was to investigate the therapeutic effects and mechanism of platycodin in liver complications of type 2 diabetes. All rats were randomly divided into two groups: The control group (normal diet) and the model group (a high‑fat and high‑sugar diet). The model group was injected with 2% streptozocin (25 mg/kg body weight) through the tail vein following 4 weeks of dieting. After a total of 8 weeks of dieting, fasting blood glucose (FBG) and liver function were examined. The high‑fat and high‑sugar diet was continued in the successful model rats, which were randomly divided into four groups and treated with the following doses of platycodins: The untreated, and 50, 100 and 200 mg/kg body weight/day groups. Platycodins treatment lasted for 12 weeks. Platycodins treatment at a dose of 200 mg/kg body weight/day reduced the FBG, glutamate pyruvate transaminase (GPT), glutamic oxalacetic transaminase, triglycerides, total cholesterol (TC), low‑density lipoprotein (LDL) and liver index levels compared with the untreated group (P<0.05), while the high‑density lipoprotein levels increased (P<0.05). Furthermore, FBG, GPT, TC and LDL levels were returned to the normal level. This dose also increased the expression of BMP‑9 mRNA and BMP‑9 protein, and reduced the expression of Smad‑4 mRNA and Smad‑4 protein. These findings indicate that platycodins can rectify disorders of blood glucose and lipid metabolism, improve liver index and protect liver function in liver complications of type 2 diabetes. The current study suggests that this therapeutic effect is mediated through the BMP‑9/Smad‑4 pathway.

View Figures

View References

1	Gujral UP, Pradeepa R, Weber MB, Narayan KM and Mohan V: Type 2 diabetes in South Asians: similarities and differences with white Caucasian and other populations. Ann NY Acad Sci. 1281:51–63. 2013. View Article : Google Scholar : PubMed/NCBI
2	Börgeson E and Godson C: Resolution of inflammation: therapeutic potential of pro-resolving lipids in type 2 diabetes mellitus and associated renal complications. Front Immunol. 3:3182012.PubMed/NCBI
3	Uslu S, Kebapçi N, Kara M and Bal C: Relationship between adipocytokines and cardiovascular risk factors in patients with type 2 diabetes mellitus. Exp Ther Med. 4:113–120. 2012.PubMed/NCBI
4	Sen S, Chen S, Feng B, Iglarz M and Chakrabarti S: Renal, retinal and cardiac changes in type 2 diabetes are attenuated by macitentan, a dual endothelin receptor antagonist. Life Sci. 91:658–668. 2012. View Article : Google Scholar : PubMed/NCBI
5	Tovilla-Zárate C, Juárez-Rojop I, Peralta Jimenez Y, et al: Prevalence of anxiety and depression among outpatients with type 2 diabetes in the Mexican population. PLoS One. 7:e368872012.PubMed/NCBI
6	Salas-Flores R, González-Pérez B and Echegollen-Guzmán A: Hepatic steatosis and type 2 diabetes mellitus in health workers. Rev Med Inst Mex Seguro Soc. 50:13–18. 2012.PubMed/NCBI
7	Song JJ, Celeste AJ, Kong FM, et al: Bone morphogenetic protein-9 binds to liver cells and stimulates proliferation. Endocrinology. 136:4293–4297. 1995.PubMed/NCBI
8	López-Coviella I, Berse B, Krauss R, Thies RS and Blusztajn JK: Induction and maintenance of the neuronal cholinergic phenotype in the central nervous system by BMP-9. Science. 289:313–316. 2000.
9	Miller AF, Harvey SA, Thies RS and Olson MS: Bone morphogenetic protein-9. An autocrine/paracrine cytokine in the liver. J Biol Chem. 275:17937–17945. 2000. View Article : Google Scholar : PubMed/NCBI
10	Suttapreyasri S, Koontongkaew S, Phongdara A and Leggat U: Expression of bone morphogenetic proteins in normal human intramembranous and endochondral bones. Int J Oral Maxillofac Surg. 35:444–452. 2006. View Article : Google Scholar : PubMed/NCBI
11	Miyazono K: TGF-beta/SMAD signaling and its involvement in tumor progression. Biol Pharm Bull. 23:1125–1130. 2000. View Article : Google Scholar : PubMed/NCBI
12	Ten Dijke P, Goumans MJ, Itoh F and Itoh S: Regulation of cell proliferation by Smad proteins. J Cell Physiol. 191:1–16. 2002.PubMed/NCBI
13	Feng XH and Derynck R: A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity. EMBO J. 16:3912–3923. 1997. View Article : Google Scholar : PubMed/NCBI
14	Bedossa P and Paradis V: Transforming growth factor-beta (TGF-beta): a key-role in liver fibrogenesis. J Hepatol. 22(Suppl): 37–42. 1995.PubMed/NCBI
15	Attisano L and Wrana JL: Signal transduction by the TGF-beta superfamily. Science. 296:1646–1647. 2002. View Article : Google Scholar : PubMed/NCBI
16	Ma G, Guo W, Zhao L, et al: Two new triterpenoid saponins from the root of Platycodon grandiflorum. Chem Pharm Bull (Tokyo). 61:101–104. 2013. View Article : Google Scholar : PubMed/NCBI
17	Fu WW, Fu JN, Zhang WM, et al: Platycoside O, a new triterpenoid saponin from the roots of Platycodon grandiflorum. Molecules. 16:4371–4378. 2011. View Article : Google Scholar : PubMed/NCBI
18	Li W, Zhang W, Xiang L, et al: Platycoside N, a new oleanane-type triterpenoid saponin from the roots of Platycodon grandiflorum. Molecules. 15:8702–8708. 2010. View Article : Google Scholar : PubMed/NCBI
19	Choi YH, Yoo DS, Choi CW, et al: Platyconic acid A, a genuine triterpenoid saponin from the roots of Platycodon grandiflorum. Molecules. 13:2871–2879. 2008. View Article : Google Scholar : PubMed/NCBI
20	Fu WW, Shimizu N, Dou DQ, et al: Five new triterpenoid saponins from the roots of Platycodon grandiflorum. Chem Pharm Bull (Tokyo). 54:557–560. 2006. View Article : Google Scholar : PubMed/NCBI
21	Hu A-M, Xiao F-Y and Zheng Y: Establishing and valuating animal model resembling to type two diabetes mellitus with intercurrent fatty liver. Chin J Int Trad Western Med Digestion. 14:156–159. 2006.(In Chinese).
22	Reed MJ, Meszaros K, Entes LJ, et al: A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism. 49:1390–1394. 2000. View Article : Google Scholar : PubMed/NCBI
23	Lee KJ, Choi CY, Chung YC, et al: Protective effect of saponins derived from roots of Platycodon grandiflorum on tert-butyl hydroperoxide-induced oxidative hepatotoxicity. Toxicol Lett. 147:271–282. 2004. View Article : Google Scholar : PubMed/NCBI
24	Lee KJ, You HJ, Park SJ, et al: Hepatoprotective effects of Platycodon grandiflorum on acetaminophen-induced liver damage in mice. Cancer Lett. 174:73–81. 2001.
25	Lee KJ and Jeong HG: Protective effect of Platycodi radix on carbon tetrachloride-induced hepatotoxicity. Food Chem Toxicol. 40:517–525. 2002. View Article : Google Scholar : PubMed/NCBI
26	Kim TW, Lee HK, Song IB, et al: Platycodin D attenuates bile duct ligation-induced hepatic injury and fibrosis in mice. Food Chem Toxicol. 51:364–369. 2013. View Article : Google Scholar : PubMed/NCBI
27	Lee H, Bae S, Kim YS and Yoon Y: WNT/β-catenin pathway mediates the anti-adipogenic effect of platycodin D, a natural compound found in Platycodon grandiflorum. Life Sci. 89:388–394. 2011.
28	Hwang YP, Choi JH, Kim HG, et al: Saponins, especially platycodin D, from Platycodon grandiflorum modulate hepatic lipogenesis in high-fat diet-fed rats and high glucose-exposed HepG2 cells. Toxicol Appl Pharmacol. 267:174–183. 2013.PubMed/NCBI
29	Lee CE, Hur HJ, Hwang JT, et al: Long-term consumption of Platycodi radix ameliorates obesity and insulin resistance via the activation of AMPK pathways. Evid Based Complement Alternat Med. 2012:7591432012.PubMed/NCBI
30	Ahn YM, Kim SK, Kang JS and Lee BC: Platycodon grandiflorum modifies adipokines and the glucose uptake in high-fat diet in mice and L6 muscle cells. J Pharm Pharmacol. 64:697–704. 2012. View Article : Google Scholar
31	Arai I, Komatsu Y, Hirai Y, et al: Stimulative effects of saponin from kikyo-to, a Japanese herbal medicine, on pancreatic exocrine secretion of conscious rats. Planta Med. 63:419–424. 1997. View Article : Google Scholar : PubMed/NCBI
32	Zhao HL, Harding SV, Marinangeli CP, Kim YS and Jones PJ: Hypocholesterolemic and anti-obesity effects of saponins from Platycodon grandiflorum in hamsters fed atherogenic diets. J Food Sci. 73:H195–H200. 2008. View Article : Google Scholar : PubMed/NCBI
33	Kim KS, Seo EK, Lee YC, et al: Effect of dietary Platycodon grandiflorum on the improvement of insulin resistance in obese Zucker rats. J Nutr Biochem. 11:420–424. 2000.
34	Zhao HL and Kim YS: Determination of the kinetic properties of platycodin D for the inhibition of pancreatic lipase using a 1,2-diglyceride-based colorimetric assay. Arch Pharm Res. 27:968–972. 2004. View Article : Google Scholar
35	Groop L: Bringing diabetes therapeutics to the big screen. Nat Biotechnol. 21:240–241. 2003. View Article : Google Scholar : PubMed/NCBI
36	Chen C, Grzegorzewski KJ, Barash S, et al: An integrated functional genomics screening program reveals a role for BMP-9 in glucose homeostasis. Nat Biotechnol. 21:294–301. 2003. View Article : Google Scholar : PubMed/NCBI
37	Kan NG, Junghans D and Izpisua Belmonte JC: Compensatory growth mechanisms regulated by BMP and FGF signaling mediate liver regeneration in zebrafish after partial hepatectomy. FASEB J. 23:3516–3525. 2009. View Article : Google Scholar : PubMed/NCBI
38	Sosa I, Cvijanovic O, Celic T, et al: Hepatoregenerative role of bone morphogenetic protein-9. Med Sci Monit. 17:HY33–HY35. 2011. View Article : Google Scholar : PubMed/NCBI
39	Machinal-Quélin F, Dieudonné MN, Leneveu MC, Pecquery R and Giudicelli Y: Proadipogenic effect of leptin on rat preadipocytes in vitro: activation of MAPK and STAT3 signaling pathways. Am J Physiol Cell Physiol. 282:C853–C863. 2002.PubMed/NCBI
40	Stadler K, Jenei V, von Bölcsházy G, Somogyi A and Jakus J: Role of free radicals and reactive nitrogen species in the late complications of diabetes mellitus in rats. Orv Hetil. 145:1135–1140. 2004.(In Hungarian).
41	Caperuto LC, Anhê GF, Cambiaghi TD, et al: Modulation of bone morphogenetic protein-9 expression and processing by insulin, glucose, and glucocorticoids: possible candidate for hepatic insulin-sensitizing substance. Endocrinology. 149:6326–6335. 2008. View Article : Google Scholar
42	Xu XB, Leng XS, He ZP, et al: Inhibitory effect of retroviral vector containing anti-sense Smad4 gene on Ito cell line, LI90. Chin Med J (Engl). 117:1170–1177. 2004.PubMed/NCBI